close

A A A
Menu

GSA Webinars

Article Index

The Effectiveness of Survivorship Models in Older Individuals
(Comparative Effectiveness in Older Cancer Patients: Age Versus Health Status Series)

November 21, 2010

This webinar highlights different considerations between younger and older individuals as it pertains to functional decline, psychosocial issues, and the role of caregivers in cancer survivors; discusses the role of functional status and comorbidity as it pertains to functional decline, psychosocial issues, and the role of caregivers in cancer survivors; and defins important unanswered questions that would benefit from comparative effectives with respect to functional decline, psychosocial issues, and the role of caregivers in cancer survivors

Presented by:

  • Charles W. Given PhD
  • Arash Naeim MD, PhD
  • Julia Hannum Rose PhD

This series, recorded during GSA's 63rd Annual Scientific Meeting, includes three sessions on topics related to comparative effectiveness research in older cancer patients. It is designed to create new opportunities for a broader national audience to discuss and provide suggestions of areas and questions that require comparative effectiveness evaluation in order to help both the provider and the older cancer patient.

The series was supported by the Agency for Healthcare Research and Quality and co-sponsored by the International Society of Geriatric Oncology, the American Geriatrics Society, and the GSA Research on Cancer and Aging Informal Interest Group.

The Effectiveness of Adjuvant Therapy in Older Individuals
(Comparative Effectiveness in Older Cancer Patients: Age Versus Health Status Series)

November 20, 2010

This webinar highlights different considerations between younger and older individuals as it pertains to breast, colon, and lung cancer adjuvant therapy; discussed the role of functional status and comorbidity with respect to the value of breast, colon, and lung cancer adjuvant therapy; and defines important unanswered questions that would benefit from comparative effectives with respect to breast, colon, and lung cancer adjuvant therapy.

Presented by:

  • Arti Hurria MD
  • Arash Naeim MD, PhD

This series, recorded during GSA's 63rd Annual Scientific Meeting, includes three sessions on topics related to comparative effectiveness research in older cancer patients. It is designed to create new opportunities for a broader national audience to discuss and provide suggestions of areas and questions that require comparative effectiveness evaluation in order to help both the provider and the older cancer patient.

The series was supported by the Agency for Healthcare Research and Quality and co-sponsored by the International Society of Geriatric Oncology, the American Geriatrics Society, and the GSA Research on Cancer and Aging Informal Interest Group.

The Effectiveness of Cancer Screening in Older Individuals
(Comparative Effectiveness in Older Cancer Patients: Age Versus Health Status Series)

November 21, 2010

This webinar highlights different considerations between younger and older individuals as it pertains to colon, prostate, and breast cancer screening; discussed the role of functional status and comorbidity with respect to the value of colon, prostate, and breast cancer screening; and defines important unanswered questions that would benefit from comparative effectives with respect to colon, prostate, and breast cancer screening.

Presented by:

  • Erica S. Breslau PhD, MPH
  • William Dale MD, PhD
  • Arash Naeim MD, PhD
  • Janine Overcash PhD, GNP-BC

This series, recorded during GSA's 63rd Annual Scientific Meeting, includes three sessions on topics related to comparative effectiveness research in older cancer patients. It is designed to create new opportunities for a broader national audience to discuss and provide suggestions of areas and questions that require comparative effectiveness evaluation in order to help both the provider and the older cancer patient.

The series was supported by the Agency for Healthcare Research and Quality and co-sponsored by the International Society of Geriatric Oncology, the American Geriatrics Society, and the GSA Research on Cancer and Aging Informal Interest Group.

Share This Page!

Print Page